Comprehensive Assessment of Polyvascular Atherosclerosis.
作者信息
Nakanishi Rine, Ikeda Takanori
机构信息
Department of Cardiovascular Medicine, Toho University Graduate School of Medicine.
出版信息
J Atheroscler Thromb. 2018 Oct 1;25(10):1005-1006. doi: 10.5551/jat.ED095. Epub 2018 Apr 28.
Abstract
摘要
相似文献
1
Comprehensive Assessment of Polyvascular Atherosclerosis.
J Atheroscler Thromb. 2018 Oct 1;25(10):1005-1006. doi: 10.5551/jat.ED095. Epub 2018 Apr 28.
2
Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
Curr Med Res Opin. 2009 Nov;25(11):2631-41. doi: 10.1185/03007990903223895.
3
Pulse Pressure: How Valuable as a Diagnostic and Therapeutic Tool?
J Am Coll Cardiol. 2016 Feb 2;67(4):404-406. doi: 10.1016/j.jacc.2015.11.022.
4
The influence of polyvascular disease on the obesity paradox in vascular surgery patients.
J Vasc Surg. 2011 Feb;53(2):399-406. doi: 10.1016/j.jvs.2010.08.048. Epub 2010 Oct 20.
5
Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics.
Metabolism. 2013 Mar;62(3):376-85. doi: 10.1016/j.metabol.2012.08.009. Epub 2012 Oct 9.
6
Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Atherosclerosis. 2011 Dec;219(2):743-9. doi: 10.1016/j.atherosclerosis.2011.08.024. Epub 2011 Aug 22.
7
My approach to risk assessment of asymptomatic patients.
Trends Cardiovasc Med. 2016 Feb;26(2):204. doi: 10.1016/j.tcm.2015.05.021. Epub 2015 Oct 22.
8
Application of the "Fat-but-Fit" paradigm in predicting 10-yr risk for an atherosclerotic cardiovascular disease (ASCVD) event using the pooled cohort risk equations among US adults.
Int J Cardiol. 2016 Jan 1;202:297-9. doi: 10.1016/j.ijcard.2015.09.057. Epub 2015 Sep 25.
9
[Multiple therapies in patients with polyvascular disease. Antithrombotic agents].
Rev Med Interne. 2007 Jun;28 Suppl 1:S14-6. doi: 10.1016/j.revmed.2007.03.014. Epub 2007 Apr 20.
10
Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.
Vasc Med. 2010 Aug;15(4):259-65. doi: 10.1177/1358863X10373299.
引用本文的文献
1
A Neuro-Vasculo-Endocrine Approach to Menopause.
J Midlife Health. 2022 Jan-Mar;13(1):18-19. doi: 10.4103/jmh.jmh_34_22. Epub 2022 May 2.
2
Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study.
J Atheroscler Thromb. 2021 Apr 1;28(4):385-395. doi: 10.5551/jat.54098. Epub 2020 Jul 17.
本文引用的文献
1
Noninvasive Assessment of Stenotic Severity and Plaque Characteristics by Coronary CT Angiography in Patients Scheduled for Carotid Artery Revascularization.
J Atheroscler Thromb. 2018 Oct 1;25(10):1022-1031. doi: 10.5551/jat.42176. Epub 2018 Feb 16.
2
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241. doi: 10.1016/j.jacc.2017.02.001. Epub 2017 Mar 10.
3
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
J Am Coll Cardiol. 2015 Oct 13;66(15):1657-68. doi: 10.1016/j.jacc.2015.07.066.
4
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959. doi: 10.1016/j.jacc.2013.11.005. Epub 2013 Nov 12.
5
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24.
6
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7.
7
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
8
Prevalence of concomitant atherosclerotic arterial diseases in patients with significant cervical carotid artery stenosis in Taiwan.
Int J Cardiovasc Imaging. 2007 Aug;23(4):433-9. doi: 10.1007/s10554-006-9180-x. Epub 2006 Nov 22.
9
Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease.
Heart. 2005 Nov;91(11):1438-41. doi: 10.1136/hrt.2004.050906. Epub 2005 Mar 10.
Zotero 插件